Prevalence and Molecular Epidemiology of Extended-Spectrum β-Lactamase–Producing Escherichia coli and Effects of Antimicrobial Use in Multiple Pig Industry Sectors in Korea
Annals of Laboratory Medicine · 2026
DOI: 10.3343/alm.2025.0173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2026. Verfasst von Young Ah Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactamases, Anti-Bacterial Agents, Escherichia coli Infections. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
The spread of antimicrobial-resistant bacteria has close relationships among humans, animals, and the environment, necessitating the implementation of the "One Health" approach. In previous study, the prevalence and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) were investigated across multiple pig industry sectors in Korea. In this study, animal developmental stages and antimicrobial usage policies on farms were also considered.
Methods
A total of 6,288 non-duplicated samples were collected from pig farms, slaughterhouses, and their personnel from three provinces in Korea between 2020 and 2022. Antimicrobial susceptibility and ESBL gene characterization were performed on the samples.
Results
Overall, 1,084 ESBL-EC isolates were collected, with positivity detection rates of 24.7%, 23.3%, 12.7%, 3.9%, 17.2% in pigs, workers, the environment, meat, and total samples, respectively. Common ESBL types were blaCTX-M-55 (N=628), blaCTX-M-15 (N=204), and blaCTX-M-14 (N=127). Pig-derived E. coli isolates had antimicrobial resistance (AMR) rates of 80.4%, 47.2%, 32.6%, 36.7%, 43.4%, 62.4%, and 72.1% to ampicillin, piperacillin, cefazoline, ciprofloxacin, cotrimoxazole, chloramphenicol, and tetracycline, respectively. AMR rates were lower in the finishing stage pigs than in the lactating stage pigs and tended to decrease during animal development for most antimicrobials. AMR rates were higher in pig farms with a customary antimicrobial use policy than in those with a low-level antimicrobial use policy.
Conclusions
The findings highlight the significance of elucidating AMR networks among humans, animals, and the environment. Prudent antimicrobial usage and continuous AMR monitoring in the pig industry are crucial to safeguard food safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
- Department of Laboratory Medicine, Hwahong Hospital, Suwon, Korea.
- Research Institute of Bacterial Resistance and Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Infectious Disease Research Center, Seoul Clinical Laboratories, Yongin, Korea.
ORCID-Profile: Young Ah Kim, Hyunsoo Kim, Young Hee Seo, Kyungwon Lee
Förderung
- Korea Centers for Disease Control and Prevention
Zitieren
APA
Kim, Y. A., Kim, H., Seo, Y. H., & Lee, K. (2026). Prevalence and Molecular Epidemiology of Extended-Spectrum β-Lactamase–Producing Escherichia coli and Effects of Antimicrobial Use in Multiple Pig Industry Sectors in Korea. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2025.0173
Vancouver
Kim YA, Kim H, Seo YH, Lee K. Prevalence and Molecular Epidemiology of Extended-Spectrum β-Lactamase–Producing Escherichia coli and Effects of Antimicrobial Use in Multiple Pig Industry Sectors in Korea. Annals of Laboratory Medicine. 2026. doi:10.3343/alm.2025.0173
BibTeX
@article{Kim2026,
author = {Kim, Young Ah and Kim, Hyunsoo and Seo, Young Hee and Lee, Kyungwon},
title = {Prevalence and Molecular Epidemiology of Extended-Spectrum β-Lactamase–Producing Escherichia coli and Effects of Antimicrobial Use in Multiple Pig Industry Sectors in Korea},
journal = {Annals of Laboratory Medicine},
year = {2026},
doi = {10.3343/alm.2025.0173}
}
EUVIMED